<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><link rel="stylesheet" href="/css/isb.css" /><title>ProteomeXchange Dataset PXD000185</title>
</head><body bgcolor="#f4f6f8" marginwidth="0" marginheight="0">	<table width="100%" height="127" background="/images/topbackground.jpg" style="box-shadow: 0 6px 8px 0 rgba(0,0,0,0.3);">	<tr align="center"><td><a href="http://www.proteomexchange.org/" border="0"><img src="/images/proteomexchange.png"></a></td><td><a href="http://proteomecentral.proteomexchange.org/" border="0"><img src="/images/proteomecentral.png"></a></td></tr>	</table>		<!-- Main content area here --><!-- BEGIN main content -->

	 <link rel='stylesheet' id='style-css'  href='../javascript/css/patchwork.css' type='text/css' media='all' />
         <script type="text/javascript" src="/javascript/js/toggle.js"></script>
      
       <div id="main">
       <a class="linkback" href="http://proteomecentral.proteomexchange.org/cgi/GetDataset"> &lt;&lt;&lt; Full experiment listing </a>
       <div id="dataset-primary" class="site-content">
       <h1 class="dataset-title">PXD000185</h1>
    
	<div class="dataset-content">
	PXD000185 is an <b>original dataset</b> announced via ProteomeXchange.<BR><BR><div class='dataset-secthead'>Dataset Summary</div>
<table class='dataset-summary'><tr><td><b>Title</b></td><td>Kinase Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells</td></tr><tr><td><b>Description</b></td><td class='breakwords'>Experiments were performed in AML (Acute Myeloid Leukemia) cell lines and in primary cells coming from patients with AML and healthy donors.  The AML cell lines P31/Fuj and Kasumi-1 were treated with vehicle (DMSO), 100 nM or 1000 nM of the PI3K/mTOR inhibitor AZ123 or the mTOR inhibitor Ku0063794 for 2h. Both cell lines were treated also with vehicle and 1000 nM of the PI3K/mTOR inhibitor PI103. 6 replicates per condition were done.  AML primary cells and GMPBs (G-CSF-mobilized peripheral blood cell) from patients and healthy donors respectively were  treated or untreated with 100 mM sodium pervanadate for 30 min. Samples 45-46 correspond to the GMPBs and the rest correspond to AML patients.   All samples were digested with trypsin and subjected to phosphoenrichment usin TiO2. Phosphopeptides were run in a LTQ-Orbitrap-XL.  Peaks lists were generated with Mascot Distiller (version 2.3) in MGF format and Database searches were with Mascot Server (version 2.3) against the SwissProt database restricted to human sequences (release December 2011) and trypsin cleavage. Restrictions were 7ppm for parent ions and 600 mmu for fragment masses. Allowed modifications were phosphorylation of Ser/Thr/Tyr, pyro-Glu (N-term) and methionine oxidation and one miss-cleavage allowed. Quantification was by label-free using peak heights of extracted ion chromatograms (XICs) constructed with narrow mass windows (7ppm) and time windows (1.5 minutes). Pescal, a computer program written in house, was used to automate the generation of XICs and to calculate peak heights.</td></tr><tr><td><b>HostingRepository</b></td><td>PRIDE</td></tr><tr><td><b>AnnounceDate</b></td><td>2013-04-11</td></tr>
                <tr><td><b>AnnouncementXML</b></td><td><a href='GetDataset?ID=PXD000185-2&outputMode=XML&test=no' target="_blank">Submission_2013-04-11_08:29:37.xml</a></td></tr>
                <tr><td><b>DigitalObjectIdentifier</b></td><td><a href="http://dx.doi.org/10.6019/PXD000185" target="_blank">http://dx.doi.org/10.6019/PXD000185</a></td></tr><tr><td><b>ReviewLevel</b></td><td>Peer-reviewed dataset</td></tr><tr><td><b>DatasetOrigin</b></td><td>Original dataset</td></tr><tr><td><b>RepositorySupport</b></td><td>Supported dataset by repository</td></tr><tr><td><b>PrimarySubmitter</b></td><td>Pedro Casado-Izquierdo</td></tr><tr><td><b>SpeciesList</b></td><td> scientific name: Homo sapiens (Human);  NCBI TaxID: 9606; </td></tr><tr><td><b>ModificationList</b></td><td>phosphorylated residue: 79.966331; monohydroxylated residue: 15.994915; iodoacetamide -site C: 57.021464; 2-pyrrolidone-5-carboxylic acid (Gln): -17.026549; N-formylated residue: 27.994915</td></tr><tr><td><b>Instrument</b></td><td>LTQ Orbitrap</td></tr></table>
<div class='dataset-secthead'>Dataset History</div>
<table class="dataset-summary">
<tr><th>Revision</th><th>Datetime</th><th>Status</th><th>ChangeLog Entry</th></tr>
<tr><td >0</td><td >2013-03-18 05:52:55</td><td >ID requested</td><td ></td></tr>
<tr><td ><a href="GetDataset?ID=PXD000185-1&test=no">1</a></td><td >2013-04-09 09:11:39</td><td >announced</td><td ></td></tr>
<tr><td ><a href="GetDataset?ID=PXD000185-1&test=no">1</a></td><td >2014-07-28 00:31:11</td><td >announced</td><td ></td></tr>
<tr><td class="dataset-currentrev"><a href="GetDataset?ID=PXD000185-2&test=no"><span class='current'>&#9205;</span> 2</a></td><td class="dataset-currentrev">2013-04-11 08:29:37</td><td class="dataset-currentrev">announced</td><td class="dataset-currentrev">Add reference</td></tr>
</table>
<div class='dataset-secthead'>Publication List </div>
<table class='dataset-summary'>
<tr><td>Casado P, Rodriguez-Prados JC, Cosulich SC, Guichard S, Vanhaesebroeck B, Joel S, Cutillas PR, Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal, 6(268):rs6(2013) [<a href="https://www.ncbi.nlm.nih.gov/pubmed?term=23532336" target="_blank">pubmed</a>]</td></tr></table>
<div class='dataset-secthead'>Keyword List </div>
<table class='dataset-summary'>
<tr><td>submitter keyword: PI3K/mTOR inhibitors, AML Primary Cells, Label Free Quantification, TiO2 phosphoenrichment</td></tr></table>
<div class='dataset-secthead'>Contact List </div>
<table class='dataset-summary'>
<tr><th colspan='2'>Pedro R. Cutillas</th></tr>
<tr><td>contact attribute</td><td>pedro.cutillas@csc.mrc.ac.uk</td></tr><tr><td>contact affiliation</td><td>Medical Researh Council Clinical Sciences Centre, Imperial Collegel</td></tr><tr><td>contact email</td><td>pedro.cutillas@csc.mrc.ac.uk</td></tr><tr><th colspan='2'>Pedro Casado-Izquierdo</th></tr>
<tr><td>contact affiliation</td><td>Cell Signalling</td></tr><tr><td>contact email</td><td>p.m.casado-izquierdo@qmul.ac.uk</td></tr></table>
<div class='dataset-secthead'>Full Dataset Link List </div>
<table class='dataset-summary'>
<tr><td><a href=ftp://ftp.pride.ebi.ac.uk/2013/04/PXD000185 target="_blank">Dataset FTP location</a></td></tr></table>

		 <div class='dataset-secthead'>Repository Record List </div>
                 <div id="less" onclick='toggle("less","more","repositoryRecordList")' title='Expand Record List'>[ + ]</div>
		 <div id="more" onclick='toggle("more","less","repositoryRecordList")' title='Hide Record List' style='display: none'>[ - ]</div>
		 <ul id="repositoryRecordList" style='display: none'>
        <li>PRIDE<ol><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28869" target="_blank">28869</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: PI103 P31 Exp1</li><li>ModificationList: phosphorylated residue, monohydroxylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of PI103 in P31 Cells  File 1 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28864" target="_blank">28864</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Ku Kas Exp2</li><li>ModificationList: phosphorylated residue, monohydroxylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of Ku in Kas Cells  File 2 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28863" target="_blank">28863</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Ku Kas Exp1</li><li>ModificationList: phosphorylated residue, monohydroxylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of Ku in Kas Cells  File 1 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28860" target="_blank">28860</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: AZ123 Kas Exp2</li><li>ModificationList: phosphorylated residue, iodoacetamide -site C, monohydroxylated residue, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of AZ123 in Kas Cells  File 2 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28874" target="_blank">28874</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Primary Cells 4 of 5</li><li>ModificationList: phosphorylated residue, monohydroxylated residue, N-formylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Phosphoproteome of AML primary cells and GMPB 4 of 5</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28875" target="_blank">28875</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Primary Cells 5 of 5</li><li>ModificationList: N-formylated residue, monohydroxylated residue, phosphorylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Phosphoproteome of AML primary cells and GMPB 4 of 5</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28867" target="_blank">28867</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: PI103 Kas Exp1</li><li>ModificationList: phosphorylated residue, monohydroxylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of PI103 in Kas Cells  File 1 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28868" target="_blank">28868</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: PI103 Kas Exp2</li><li>ModificationList: phosphorylated residue, iodoacetamide -site C, monohydroxylated residue, </li><li>Name: Effects of PI103 in Kas Cells  File 2 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28866" target="_blank">28866</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Ku P31 Exp2</li><li>ModificationList: phosphorylated residue, iodoacetamide -site C, monohydroxylated residue, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of Ku in P31 Cells  File 2 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28859" target="_blank">28859</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: AZ123 Kas Exp1</li><li>ModificationList: phosphorylated residue, monohydroxylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of AZ123 in Kas Cells  File 1 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28865" target="_blank">28865</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Ku P31 Exp1</li><li>ModificationList: phosphorylated residue, iodoacetamide -site C, monohydroxylated residue, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of Ku in P31 Cells  File 1 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28862" target="_blank">28862</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: AZ123 P31 Exp2</li><li>ModificationList: phosphorylated residue, iodoacetamide -site C, monohydroxylated residue, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of AZ123 in P31 Cells  File 2 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28872" target="_blank">28872</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Primary Cells 2 of 5</li><li>ModificationList: phosphorylated residue, N-formylated residue, monohydroxylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Phosphoproteome of AML primary cells and GMPB 2 of 5</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28871" target="_blank">28871</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Primary Cells 1 of 5</li><li>ModificationList: monohydroxylated residue, phosphorylated residue, N-formylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Phosphoproteome of AML primary cells and GMPB 1 of 5</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28873" target="_blank">28873</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: Primary Cells 3 of 5</li><li>ModificationList: phosphorylated residue, N-formylated residue, monohydroxylated residue, 2-pyrrolidone-5-carboxylic acid (Gln), iodoacetamide -site C, </li><li>Name: Phosphoproteome of AML primary cells and GMPB 3 of 5</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28870" target="_blank">28870</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: PI103 P31 Exp2</li><li>ModificationList: monohydroxylated residue, phosphorylated residue, iodoacetamide -site C, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of PI103 in P31 Cells  File 2 of 2</li><li>PublicationRef: PMID23532336</li></ol></li><li><a href="http://www.ebi.ac.uk/pride/simpleSearch.do?simpleSearchValue=28861" target="_blank">28861</a><ol><li>InstrumentRef: INSTRUMENT_1</li><li>Label: AZ123 P31 Exp1</li><li>ModificationList: iodoacetamide -site C, phosphorylated residue, monohydroxylated residue, 2-pyrrolidone-5-carboxylic acid (Gln), </li><li>Name: Effects of AZ123 in P31 Cells  File 1 of 2</li><li>PublicationRef: PMID23532336</li></ol></li></li></ul>

      
	 </div><!-- #content -->
	 </div><!-- #primary .site-content -->
	 </div><!-- #main -->
      <!-- END main content -->	<!-- Begin Footer -->	<br clear="all">	<div class="footer">	<table width="100%"><tr>	<td style="vertical-align:top; text-align:left; padding: 10px;">If you have a question or comment about ProteomeXchange, please <a href="http://www.proteomexchange.org/contact">contact us</a>!<BR>	<a href="http://www.proteomexchange.org/subscribe/index.html"><img width="70" height="20" src="/images/subscribe_button-small.jpg"><font size="+1" color="#aa0000"> to receive all new ProteomeXchange dataset release announcements!</font></a>	</td>	<td style="text-align:right; padding: 10px;">	<a class="logolink" target="_blank" href="http://www.ebi.ac.uk/"><img src="/images/ebi_footer_logo.png"></a>&nbsp;&nbsp;&nbsp;&nbsp;	<a class="logolink" target="_blank" href="http://www.isbscience.org/"><img src="/images/isb.jpg"></a>&nbsp;&nbsp;&nbsp;&nbsp;	<a class="logolink" target="_blank" href="http://ec.europa.eu/research/fp7/index_en.cfm"><img src="/images/capacities.png"></a>	</td></tr></table>	</div>				</body></html>